Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Dutzu Rosner"'
Publikováno v:
Cancer Investigation. 13:573-582
The current study attempted to assess the potential proficiency of radioimmunodetection (RAID) of primary, residual, multicentric, and recurrent breast carcinoma using two radiolabeled murine monoclonal antibodies (MoAbs), anti-human milk fat globuli
Autor:
Dutzu Rosner, Warren W. Lane
Publikováno v:
Cancer. 68:1482-1494
This study, which used combined first-generation prognostic factors (tumor size, histologic differentiation, and age) on 408 patients with axillary node-negative (ANN) breast cancer treated by surgery alone without systemic adjuvant therapy between 1
Publikováno v:
Cancer. 67:1498-1503
Of 408 negative axillary node (NAN) patients surgically treated at Roswell Park Cancer Institute (Buffalo, NY, 1976 through 1987), 36 (8.8%) presented with ductal carcinoma in situ with microinvasion (DCISM). In more than 50% of the patients (20/36)
Autor:
Dutzu Rosner, Warren W. Lane
Publikováno v:
Cancer. 66:199-205
Ninety-one patients with invasive breast carcinoma with a diameter of 1 cm or less and histologically negative axillary nodes were treated between 1976 and 1986 with radical surgery alone (67), or with conservative surgery (24). Cases were analyzed i
Publikováno v:
Cancer. 63:1673-1675
Aminoglutethimide (AG) was administered as palliative therapy in 112 patients with metastatic breast cancer. In 36 patients, the dose level was 1000 mg/day; 76 patients received a dose level of 500 mg/day. Patients with brain or liver metastasis were
Autor:
Warren W. Lane, Dutzu Rosner
Publikováno v:
Breast cancer research and treatment. 25(2)
This study attempted to identify the risk groups in axillary node negative breast cancer patients using validated first-generation prognostic clinical and pathologic factors. An updated 10-year follow-up in 407 such patients treated by surgery alone
Publikováno v:
American Journal of Clinical Pathology. 62:281-289
Cell-mediated immune challenge reactions to diverse antigens at tumor sites result in regressions of various types of malignant lesions. Regressions of accessible lesions vary from partial to complete and last from several months to more than 5 years
Publikováno v:
Journal of Surgical Oncology. 41:226-229
A clinical trial of sequential tamoxifen and medroxyprogesterone acetate (MPA) was carried out in 36 women with metastatic breast cancer in order to evaluate the therapeutic efficacy of this regimen and to determine if tamoxifen would increase proges
Publikováno v:
Journal of Surgical Oncology. 30:52-59
Among 193 breast cancer patients aged 35-50 years, there was no appreciable difference in the extent of disease at diagnosis between 53 oral contraceptive (OC) users and 140 OC non-users. There was no overall significant difference between OC users a
Publikováno v:
Journal of Surgical Oncology. 14:83-96
Two hundred nine patients with breast disease were examined with a new advanced ultrasonic scanner. The ultrasound data were compared with clinical examination and, when available, X-ray, surgical, and pathologic observations. The main purpose of the